Cargando…
Where Do We Stand in Stem Cell Therapy for the Management of Diabetes Mellitus?—A Scientometric Research Trend Analysis from 1990 to 2020
Stem cell therapy has been considered a promising strategy in the management of both type I and type II diabetes mellitus (DM) because of its immunomodulatory and regenerative capability to restore the beta cell number and function. Various modalities of cellular therapy like transplantation of panc...
Autores principales: | Muthu, Sathish, Jeyaraman, Madhan, Jeyaraman, Naveen, Rajendran, Ramya Lakshmi, Gangadaran, Prakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615097/ https://www.ncbi.nlm.nih.gov/pubmed/34821725 http://dx.doi.org/10.3390/bioengineering8110159 |
Ejemplares similares
-
Evolution of evidence in spinal surgery – past, present and future Scientometric analysis of randomized controlled trials in spinal surgery
por: Muthu, Sathish, et al.
Publicado: (2022) -
Osteogenic and Chondrogenic Potential of Periosteum-Derived Mesenchymal Stromal Cells: Do They Hold the Key to the Future?
por: Jeyaraman, Madhan, et al.
Publicado: (2021) -
Is Culture Expansion Necessary in Autologous Mesenchymal Stromal Cell Therapy to Obtain Superior Results in the Management of Knee Osteoarthritis?—Meta-Analysis of Randomized Controlled Trials
por: Muthu, Sathish, et al.
Publicado: (2021) -
Comparative effectiveness of adipose-derived mesenchymal stromal cells in the management of knee osteoarthritis: A meta-analysis
por: Muthu, Sathish, et al.
Publicado: (2023) -
Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)—An Indian Perspective
por: Muthu, Sathish, et al.
Publicado: (2022)